NuFund Venture Group announces investment in Resolute Science, a preclinical-stage biotechnology company developing a pan-cancer platform targeting tumor-associated macrophages to deliver cytotoxic ...

Nearly 60,000 people are diagnosed with oral cancer in the U.S. every year, according to the American Cancer Society, and the ...